Nirav R. Shah, MD

Conference Coverage

Bispecific Lentiviral Anti-CD20/Anti-CD19 CAR T-Cells for R/R MCL

12/21/2023

During the 2023 ASH Annual Meeting in San Diego, Nirav N Shah, MD, discussed the efficacy of dual-targeted lentiviral anti-CD20/anti-CD19 (LV20.19) CAR T-cells with an adaptive manufacturing process among patients with relapsed/refractory...

During the 2023 ASH Annual...

12/21/2023

Oncology

Videos

Exploring New Therapies on the Horizon for Patients With R/R Chronic Lymphocytic Leukemia

08/09/2024

Nirav R. Shah , MD;

Nirav Shah, MD, shares insights into the research on exciting new therapies for patients with relapsed/refractory chronic lymphocytic leukemia, including BTK degraders and cell therapies.

Nirav Shah, MD, shares insights...

08/09/2024

Oncology

The Use of Non-Contact Low Energy Ultrasound Therapy* to Treat Frostbite for Post-Op Complication

Introduction: Frostbite is an injury caused by freezing of the skin and underlying tissue whereupon the skin becomes very cold and red, then numb, hard and pale. Frostbite occurs in ...

Nirav R. Shah , MD;

Donald E. Mrdjenovich ;

08/19/2019